These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33725824)

  • 1. Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA).
    Heshmatzadeh Behzadi A; Amoozgar B; Jain S; Velasco N; Zahid U; Abbasi H; Alasadi L; Prince MR
    Medicine (Baltimore); 2021 Mar; 100(10):e24603. PubMed ID: 33725824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials.
    Nadkarni GN; Konstantinidis I; Patel A; Yacoub R; Kumbala D; Patel RA; Annapureddy N; Pakanati KC; Simoes PK; Javed F; Benjo AM
    J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):539-46. PubMed ID: 25715308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis.
    Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
    Medicine (Baltimore); 2017 Mar; 96(9):e6059. PubMed ID: 28248861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimetazidine can prevent the occurrence of contrast-induced nephropathy after percutaneous coronary intervention in elderly patients with renal insufficiency.
    Fu H; Zhang J; Zhang H; Zhang P; Fu X; Zeng Z; Zhang X; Li W; Yang S; Liu X; Fu N
    Perfusion; 2021 Sep; 36(6):603-609. PubMed ID: 32909511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study.
    Chen F; Liu F; Lu J; Yang X; Xiao B; Jin Y; Zhang J
    Eur J Med Res; 2018 May; 23(1):23. PubMed ID: 29776437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine Prevention of Contrast-Induced Nephropathy in Coronary Angiography.
    Liu W; Ming Q; Shen J; Wei Y; Li W; Chen W; Xu Y
    Am J Med Sci; 2015 Nov; 350(5):398-402. PubMed ID: 26445302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease.
    Ibrahim TA; El-Mawardy RH; El-Serafy AS; El-Fekky EM
    Cardiovasc Revasc Med; 2017; 18(5):315-319. PubMed ID: 28532702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of trimetazidine on contrast-induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention - A systematic review and meta-analysis.
    Martha JW; Pranata R; Wibowo A; Irvan I; Afrianti R; Akbar MR
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):3045-3053. PubMed ID: 33877668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure.
    Tamura A; Goto Y; Miyamoto K; Naono S; Kawano Y; Kotoku M; Watanabe T; Kadota J
    Am J Cardiol; 2009 Oct; 104(7):921-5. PubMed ID: 19766757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimetazidine in the prevention of contrast induced nephropathy after coronary angiogram.
    Rahman MM; Haque SS; Rokeya B; Siddique MA; Banerjee SK; Ahsan SA; Rahman F; Mahmood M; Ahmed K; Bhuiyan MM; Joarder AI; Debnath RC
    Mymensingh Med J; 2012 Apr; 21(2):292-9. PubMed ID: 22561774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials.
    Pandya B; Chalhoub JM; Parikh V; Gaddam S; Spagnola J; El-Sayegh S; Bogin M; Kandov R; Lafferty J; Bangalore S
    Int J Cardiol; 2017 Feb; 228():137-144. PubMed ID: 27863354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography.
    Calabrò P; Bianchi R; Crisci M; Caprile M; Bigazzi MC; Palmieri R; Golia E; De Vita A; Romano IJ; Limongelli G; Russo MG; Calabrò R
    Intern Emerg Med; 2011 Dec; 6(6):503-7. PubMed ID: 21279477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.
    Onbasili AO; Yeniceriglu Y; Agaoglu P; Karul A; Tekten T; Akar H; Discigil G
    Heart; 2007 Jun; 93(6):698-702. PubMed ID: 17065180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
    Nawa T; Nishigaki K; Kinomura Y; Tanaka T; Yamada Y; Kawasaki M; Minatoguchi S
    Int J Cardiol; 2015 Sep; 195():228-34. PubMed ID: 26048382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Contrast-induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Elective Coronary Angioplasty or Angiography with Sodium Potassium Citrate Solution, a Double Blind Randomized Clinical Trial.
    Ghorbani A; Yazdankhah S; Adel MH; Tabesh H; Sattari AR; Sattari SA; Heybar H; Madjidi S
    Iran J Kidney Dis; 2019 May; 13(3):182-190. PubMed ID: 31209191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.
    Mueller C; Buerkle G; Buettner HJ; Petersen J; Perruchoud AP; Eriksson U; Marsch S; Roskamm H
    Arch Intern Med; 2002 Feb; 162(3):329-36. PubMed ID: 11822926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive Effect of Trimetazidine on Contrast-Induced Acute Kidney Injury in CKD Patients Based on Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL): A randomized Clinical Trial.
    Mirhosseni A; Farahani B; Gandomi-Mohammadabadi A; Keyvani H; Biglari-Abhari M; Davari A; Vazirizade-Mahabadi MH; Savaj S
    Iran J Kidney Dis; 2019 May; 13(3):191-197. PubMed ID: 31209192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Liu Y; Hong D; Wang AY; Guo R; Smyth B; Liu J; Sun G; Chen S; Tan N; Jardine M; Brieger D; Shaman A; Islam S; Chen J; Gallagher M
    BMC Cardiovasc Disord; 2019 Apr; 19(1):87. PubMed ID: 30961544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.